Oncology Pharma Inc.
ONPH
OTC PK
| 12/31/2004 | 09/30/2004 | 06/30/2004 | 03/31/2004 | 12/31/2003 | |
|---|---|---|---|---|---|
| Net Income | 66.56% | 37.85% | 14.89% | -2.96% | 8.67% |
| Total Depreciation and Amortization | -92.36% | -85.96% | -83.07% | -79.49% | -61.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -162.40% | -161.42% | -160.48% | -464.86% | 247.06% |
| Change in Net Operating Assets | -17.47% | 36.80% | -618.29% | -7.02% | -286.05% |
| Cash from Operations | 45.14% | 18.45% | -67.25% | -38.50% | -1.16% |
| Capital Expenditure | 100.00% | 100.00% | 81.52% | 88.44% | 92.24% |
| Sale of Property, Plant, and Equipment | 6,550.00% | 6,550.00% | 6,550.00% | 6,550.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 986.67% | 838.89% | 228.89% | 180.00% | 93.15% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -100.00% | 46,500.00% | 46,500.00% | -25.64% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -37.23% | -65.10% | 62,800.00% | 54,500.00% | -26.43% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 63.80% | 11.10% | 8.76% | 15.74% | 1.35% |